Nine Months 2019 Hansa Biopharma AB Earnings Call Transcript
Hello, ladies and gentlemen, and welcome to the Hansa Biopharma AB interim report for January to September 2019. (Operator Instructions) Today, I'm pleased to present the CEO, Søren Tulstrup. Speaker, please begin.
¸ - ()-&
Thank you, operator. Good afternoon to those of you in Europe and good morning to those in the U.S. Welcome to the Hansa Biopharma conference call for the results for the first 9 months of 2019. I'm Søren Tulstrup, CEO and Anabitarte. With me today, I have our CFO, Donato Spota; as well as our Head of Investor Relations, Klaus Sindahl.
Today, we'll review the overall progress and highlights the third quarter as well as the near-term milestones. Our presentation should take about 15 minutes, and after that we'll take your questions. Now please turn to Slide 2. Please allow me to draw your attention to our forward-looking statements, which applies to this presentation. Now please turn to Slide 3. As a biopharma
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |